Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Thorac Oncol. 2020 Apr 27;15(9):1425–1433. doi: 10.1016/j.jtho.2020.04.020

Table 2:

Trial characteristics (N=209)

Characteristic Number of trials (%) Median number of patients
(mean)
All trials 209 (100%) 38 (range 5-550); mean 67
  <40 patients 109 (52%) 24 (mean 25)
  ≥ 40 patients 100 (48%) 80 (mean 114)
Cancer type
  Lung 141 (67%) 39 (mean 74)
  Multiple cancer types 68 (33%) 37 (mean 53)
Phase
  I 120 (57%) 34 (mean 53)
  II 89 (43%) 49 (mean 86)